Epstein-barr virus: It causes mono and maybe MS. Is a vaccine near?
The mononucleosis virus, Epstein-Barr, has become a major suspect in the search for what causes multiple sclerosis.
Feb 10, 2022
0
8
The mononucleosis virus, Epstein-Barr, has become a major suspect in the search for what causes multiple sclerosis.
Feb 10, 2022
0
8
The first Australian COVID-19 mRNA vaccine candidate, developed by the Monash Institute of Pharmaceutical Sciences (MIPS), has moved a step closer with production reaching a significant development milestone.
Nov 30, 2021
0
2
Effective vaccines, without a needle: Since the start of the COVID pandemic, researchers have doubled down on efforts to create patches that deliver life-saving drugs painlessly to the skin, a development that could revolutionize ...
Oct 29, 2021
0
184
There's been a significant breakthrough in the development of a vaccine to prevent hookworm infection—a parasite which causes serious disease in tens of millions of people globally.
Oct 26, 2021
0
5
Franco-Austrian biotech lab Valneva announced Monday positive results from clinical trials of its COVID vaccine candidate, a month after the UK government terminated a supply deal with the company.
Oct 18, 2021
1
40
The British government has terminated a supply deal for a potential COVID jab being developed by French-Austrian biotech laboratory Valneva, the firm said on Monday.
Sep 13, 2021
0
3
Researchers at Vanderbilt University Medical Center (VUMC) and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks ...
Jul 16, 2021
0
6
A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be ...
Jul 15, 2021
0
14
Cuba on Friday approved its home-grown Abdala vaccine for emergency use, the first Latin American coronavirus jab to reach this stage and a possible lifeline for a region trying to battle a killer pandemic with modest means.
Jul 9, 2021
0
2
The University of Oxford today started vaccinations of a novel HIV vaccine candidate as part of a Phase I clinical trial in the UK.
Jul 5, 2021
0
2